Maryland Tech Council Applauds AstraZeneca’s Expansion in Maryland

Global Biopharma Leader’s Growth Underscores Importance of Skills Training Initiatives

Frederick, MD (February 6, 2024) – The Maryland Tech Council (MTC), the largest technology and life sciences trade association in the state, today commended AstraZeneca and the Moore Administration for the company’s newly announced manufacturing expansion in Maryland. The company, an MTC member, announced it is investing $300 million in a state-of-the-art facility in Rockville, where it will launch its life-saving cell therapy platforms in the U.S. for critical cancer trials and future commercial supply.

“We are thrilled to see AstraZeneca expand its commitment to innovation and job growth in Maryland, and congratulate the Moore Administration for working closely with AstraZeneca to make this expansion possible,” said Kelly Schulz, CEO of the Maryland Tech Council. “Today’s announcement underscores that biopharma manufacturing is a cornerstone of Maryland’s economic future, and we must act decisively to prioritize skills training and workforce solutions that position our residents for careers in this high-paying industry.”

AstraZeneca focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, and respiratory and immunology. Based in Cambridge in the United Kingdom, AstraZeneca operates in more than 100 countries and its innovative medicines are used by millions of patients worldwide. To learn more, visit

MTC has launched BioHub Maryland, an initiative to equip military veterans and members of disadvantaged communities with skills and training to enter the biopharma manufacturing field in Maryland. BioHub Maryland recently entered a game-changing skills training agreement with the National Institute of Bioprocessing Research and Training (NIBRT), a global leader in biopharmaceutical manufacturing training and research to upskill thousands of Marylanders from alternative educational backgrounds for biopharma manufacturing careers. Learn more at

One out of every three biotech job postings in Maryland last year did not require an undergraduate degree – that’s more than 6,000 jobs available to Marylanders with high school diplomas, associate degrees, or other alternative educational backgrounds.  

Learn more about AstraZeneca’s announcement at this link: Governor Moore Announces AstraZeneca to Expand Manufacturing Operations in Montgomery County.

Media Contact

Henry Fawell
(410) 212-8468